Wednesday, January 16, 2019
IBB 109.31 0.07 (0.06%)XBI 82.74 0.54 (0.66%)
Ticker Current Price Change Graph
IBB 109.31 0.07 (0.06%)
XBI 82.74 0.54 (0.66%)
Last updated: ago
Sign in to Endpoints
Menu Search Chat
  • Special Reports
  • Events
  • ENDPOINTS 100
  • News
  • Protocols
  • Bioregnum
  • Endpoints Careers
  • About
  • Advertise
  • Privacy Policy
  • Reader center

Dragonfly preps clinical takeoff, inking a collaboration pact with MD Anderson

by Amber Tongenvelope — on January 16, 2019 09:42 AM EST

UPDATED: Aptinyx shares crater as lead drug fails in PhII neuropathic pain study

by Natalie Groverenvelope — on January 16, 2019 09:01 AM EST
Updated: 10:22 AM

Allergan and its Mohawk allies pitch their sovereign immunity case to SCOTUS. And the timing couldn’t be worse

by John Carrollenvelope — on January 16, 2019 08:52 AM EST
Updated: 08:54 AM

Blocking PD-L1 production in mice, UCSF team spotlights preclinical promise of a Pfizer-partnered I/O drug

by Amber Tongenvelope — on January 16, 2019 07:14 AM EST
Updated: 07:18 AM

Live to 150? Jim Mellon and the crew at Juvenescence just raised $46M more to give it a try

by John Carrollenvelope — on January 16, 2019 06:54 AM EST
Updated: 07:03 AM

Five Prime cuts 41 jobs, days before presenting data at ASCO meeting of GI cancers

by Natalie Groverenvelope — on January 16, 2019 06:00 AM EST
Updated: 07:11 AM

Gottlieb, Marks detail plans to advance development of cell and gene therapies

by Michael Mezherenvelope — on January 16, 2019 05:07 AM EST

Harvard prof David Sinclair backs anti-aging upstart Life Bio, which just raised $50M for research

by John Carrollenvelope — on January 15, 2019 10:13 AM EST

In a first, China’s BeiGene scores FDA ‘breakthrough’ status for BTK inhibitor — potential rival for Imbruvica

by Amber Tongenvelope — on January 15, 2019 09:20 AM EST

Two more big pharma vets at Roche, AstraZeneca make the leap to top biotech R&D jobs as the great migration continues

by John Carrollenvelope — on January 15, 2019 08:47 AM EST
Updated: 10:37 AM

  • 1
  • 2
  • 3
  • 438

Contact Endpoints News

You can also contact John Carroll, Editor at john@endpointsnews.com

← Go back
  • Endpoints Careers
  • About Endpoints
  • Privacy Policy
  • Advertise

copyright 2019 Endpoints Company

Yes, I'd like to subscribe No, thanks
I'm already a subscriber
Thank you for staying with us. It's great to have you on board!
Aww, shucks. Perhaps you can tell us what we could do to make you interested in subscribing?
Sure No
← Go back

Sign in to Endpoints News

I forgot my password Request a magic link
← Go back

Request a magic link

Enter your email below to get a Magic link which lets you sign in quickly without using a password.
Please note the Magic link is one-time use only and valid for only 24 hours.
← Go back

Set a new password

We will send you a link, with which you will be able to set a new password.
Please note this link is one-time use only and valid for only 24 hours.